279 related articles for article (PubMed ID: 8922128)
1. Gene therapy of primary immunodeficiencies.
Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
[No Abstract] [Full Text] [Related]
2. Primary immunodeficiencies: molecular aspects and treatment.
Fischer A
Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525
[No Abstract] [Full Text] [Related]
3. [Gene therapy for hereditary immunodeficiencies].
Fischer A; de Saint-Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
C R Seances Soc Biol Fil; 1996; 190(1):77-93. PubMed ID: 8881271
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for inherited immunodeficiencies.
Howe S; Thrasher AJ
Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for primary immunodeficiencies.
Thrasher AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):457-71, xi. PubMed ID: 18424342
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy.
Culver KW
J Insur Med; 1996; 28(2):121-4. PubMed ID: 10163946
[No Abstract] [Full Text] [Related]
8. [Prenatal and postnatal transplantation of hematopoietic stem cells in children with primary immunodeficiency].
Porta F; Lanfranchi A; Verardi R; Mazzolari E; Verzeri U; Tettoni K; Ugazio AG
Ann Ist Super Sanita; 1999; 35(2):315-28. PubMed ID: 10645667
[TBL] [Abstract][Full Text] [Related]
9. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Cavazzana-Calvo M
Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
12. Progress in primary immunodeficiency.
Matsumoto S; Sakiyama Y; Ariga T; Gallagher R; Taguchi Y
Immunol Today; 1992 Jan; 13(1):4-5. PubMed ID: 1739431
[TBL] [Abstract][Full Text] [Related]
13. [Gene therapy for primary immunodeficiency diseases].
Ariga T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():641-5. PubMed ID: 16416867
[No Abstract] [Full Text] [Related]
14. Gene therapy for primary immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Immunol Allergy Clin North Am; 2010 May; 30(2):237-48. PubMed ID: 20493399
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of gene therapy for primary immunodeficiencies.
Chinen J; Puck JM
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):523-7. PubMed ID: 15640693
[TBL] [Abstract][Full Text] [Related]
16. Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ; Williams DA
Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy fulfilling its promise.
Kohn DB; Candotti F
N Engl J Med; 2009 Jan; 360(5):518-21. PubMed ID: 19179320
[No Abstract] [Full Text] [Related]
18. [Bone marrow transplantation in the primary immunodeficiencies].
Madero López L; Villa Alcázar M
Sangre (Barc); 1999 Apr; 44(2):135-41. PubMed ID: 10382323
[No Abstract] [Full Text] [Related]
19. Prospects for gene therapy of human disease.
Blaese RM; Culver KW
Allergol Immunopathol (Madr); 1991; 19(1):25-8. PubMed ID: 1683140
[No Abstract] [Full Text] [Related]
20. LMO2 and gene therapy for severe combined immunodeficiency.
Stone BD
N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
[No Abstract] [Full Text] [Related]
[Next] [New Search]